Clinical Trial Update: Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis [Phase 4]

View source ↗

Summary

Phase 4 multicenter randomized study evaluating whether Lotemax affects initiation of Restasis treatment in patients with dry eye disease and keratoconjunctivit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Keratoconjunctivitis Sicca

Drugs mentioned

• Lotemax (Loteprednol etabonate)
• Restasis (Cyclosporine A)

Snippet

Sponsor: Ophthalmic Consultants of Long Island | Conditions: Dry Eye Disease, Keratoconjunctivitis Sicca | Phase 4 | Status: COMPLETED